Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121591454 | 12159145 | 4 | F | 20130802 | 20160727 | 20160308 | 20160801 | EXP | PHHY2011CA112846 | NOVARTIS | 57.48 | YR | M | Y | 0.00000 | 20160801 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121591454 | 12159145 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO (EVERY 4 WEEKS) | U | 21008 | 20 | MG | /month | ||||||
| 121591454 | 12159145 | 2 | SS | NAPROXEN. | NAPROXEN | 1 | Unknown | U | 0 | ||||||||||
| 121591454 | 12159145 | 3 | C | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 121591454 | 12159145 | 4 | C | BUTRANS | BUPRENORPHINE | 1 | Unknown | U | 0 | PATCH | |||||||||
| 121591454 | 12159145 | 5 | C | STATEX | MORPHINE SULFATE | 1 | Unknown | UNK UNK, PRN | U | 0 | |||||||||
| 121591454 | 12159145 | 6 | C | TECTA | PANTOPRAZOLE MAGNESIUM | 1 | Unknown | U | 0 | ||||||||||
| 121591454 | 12159145 | 7 | C | DOCUSATE | DOCUSATE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121591454 | 12159145 | 1 | Carcinoid tumour |
| 121591454 | 12159145 | 2 | Product used for unknown indication |
| 121591454 | 12159145 | 3 | Product used for unknown indication |
| 121591454 | 12159145 | 4 | Product used for unknown indication |
| 121591454 | 12159145 | 5 | Product used for unknown indication |
| 121591454 | 12159145 | 6 | Product used for unknown indication |
| 121591454 | 12159145 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121591454 | 12159145 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121591454 | 12159145 | Asthenia | |
| 121591454 | 12159145 | Blood potassium decreased | |
| 121591454 | 12159145 | Blood pressure diastolic decreased | |
| 121591454 | 12159145 | Blood pressure fluctuation | |
| 121591454 | 12159145 | Blood pressure increased | |
| 121591454 | 12159145 | Blood pressure systolic increased | |
| 121591454 | 12159145 | Body temperature decreased | |
| 121591454 | 12159145 | Chills | |
| 121591454 | 12159145 | Diarrhoea | |
| 121591454 | 12159145 | Dizziness | |
| 121591454 | 12159145 | Fatigue | |
| 121591454 | 12159145 | Heart rate decreased | |
| 121591454 | 12159145 | Hypoglycaemia | |
| 121591454 | 12159145 | Influenza like illness | |
| 121591454 | 12159145 | Injection site pain | |
| 121591454 | 12159145 | Injection site swelling | |
| 121591454 | 12159145 | Internal haemorrhage | |
| 121591454 | 12159145 | Myalgia | |
| 121591454 | 12159145 | Stress |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121591454 | 12159145 | 1 | 20111125 | 0 |